Table 2.
Intraoperative parameters and perioperative outcomes
| Parameters | AUR (50) | CUR (38) | p | UR (88) | LUTS (80) | p |
|---|---|---|---|---|---|---|
|
| ||||||
| Operative time, min (median) | 56 (18–127) | 52.5 (18–103) | 0.486 | 54 (18–127) | 54 (21–240) | 0.535 |
|
| ||||||
| Vaporization time, min (median) | 44.5 (12–106) | 37 (12–74) | 0.292 | 42 (12–106) | 40 (13–210) | 0.504 |
|
| ||||||
| Lasing time, min (median) | 25 (8–59) | 22.5 (8–49) | 0.663 | 25 (8–59) | 28 (8–183) | 0.415 |
|
| ||||||
| Energy, kJ (median) | 169 (39–374) | 188 (38–337) | 0.258 | 173 (38–374) | 181 (40–539) | 0.306 |
|
| ||||||
| Change in Hb, g/L (median) | 8 (0–42) | 11 (3–14) | 0.398 | 8 (0–42) | 10 (0–47) | 0.444 |
|
| ||||||
| Blood transfusion, n (%) | 0 | 0 | – | 0 | 2 (2.5) | 0.497 |
|
| ||||||
| Intraoperative complications, n (%) | 0 | 0 | – | 0 | 3 (3.8) | 0.07 |
|
| ||||||
| Length of hospital stay, days (median) | 1 (0.25–1) | 1 (0.25–1) | 0.622 | 1 (0.25–1) | 1 (0.25–14) | 0.109 |
|
| ||||||
| Postoperative catheterization time, days (median) | 2.5 (0.125–7) | 1 (0.125–7) | 0.741 | 1.5 (0.125–7) | 1 (0.125–30) | <0.001 |
|
| ||||||
| Successful first TOV, n (%) | 44 (88) | 29 (76.3) | 0.148 | 73 (83) | 64 (80) | 0.764 |
|
| ||||||
| Recurrent retention after TOV, n (%) | 6 (12) | 5 (13.2) | 0.87 | 11 (12.5) | 0 | 0.008 |
|
| ||||||
| Postoperative complications, n (%) | ||||||
| Clavien I | 5 (10) | 2 (5.3) | 0.655 | 7 (8) | 8 (10) | 0.667 |
| Clavien II | 1 (2) | 1 (2.6) | 2 (2.3) | 1 (1.3) | ||
| Clavien III | 0 (0) | 0 (0) | 0 (0) | 0 (0) | ||
| Clavien IV | 0 (0) | 0 (0) | 0 (0) | 1 (1.3) | ||
AUR: acute urinary retention; CUR: chronic urinary retention; Hb: hemoglobin; TOV: trial of void; LUTS: lower urinary tract symptoms; UR: urinary retention.